American Portfolios Advisors’s VanEck Biotech ETF BBH Stock Holding History

American Portfolios Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$17K	–	3274
2020 Q4	$17K	Sell	100 -25	-20%	-$4.12K	﹤0.01%	1895
2020 Q3	$20.3K	Hold	125	–	–	﹤0.01%	1695
2020 Q2	$20.4K	Buy	125 +25	+25%	+$3.8K	﹤0.01%	1632
2020 Q1	$12.8K	Hold	100	–	–	﹤0.01%	1717
2019 Q4	$13.9K	Hold	100	–	–	﹤0.01%	1869
2019 Q3	$11.8K	Hold	100	–	–	﹤0.01%	1875
2019 Q2	$12.9K	Hold	100	–	–	﹤0.01%	1825
2019 Q1	$12.8K	Hold	100	–	–	﹤0.01%	1733
2018 Q4	$11.1K	Hold	100	–	–	﹤0.01%	1581
2018 Q3	$13.6K	Hold	100	–	–	﹤0.01%	1628
2018 Q2	$12K	Hold	100	–	–	﹤0.01%	1657
2018 Q1	$12K	Hold	100	–	–	﹤0.01%	1571
2017 Q4	$12.5K	Buy	+100	New	+$12.8K	﹤0.01%	1499

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

American Portfolios Advisors's BBH Position: Q1 2021 in Review

American Portfolios Advisors sold out of VanEck Biotech ETF (BBH) in Q1 2021, closing a stake of 100 shares — an estimated $17K sold.

American Portfolios Advisors first reported a position in BBH in Q4 2017 and held it in 13 quarters. The position peaked at $20.4K in Q2 2020. 105 funds tracked by Wall St. Rank hold BBH as of Q1 2021.

American Portfolios Advisors reported no remaining VanEck Biotech ETF position as of Q1 2021 after selling out during the quarter.
American Portfolios Advisors sold 100 VanEck Biotech ETF shares in Q1 2021, an estimated $17K.
American Portfolios Advisors first reported a position in VanEck Biotech ETF in Q4 2017 and held it in 13 quarters.
American Portfolios Advisors's VanEck Biotech ETF position peaked at $20.4K in Q2 2020.
105 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.